Wiebe 1999 A.
Methods | see Wiebe 1999 | |
Participants | see Wiebe 1999 | |
Interventions | Phase 2: group 1: Tamoxifen 40 mg/day for 4 days (= total dose of 160mg) and misoprostol 800 mcg/pv > 48 hours group 2: Methotrexate 50 mg/m2 and misoprostol 800mcg/pv >96 hours | |
Outcomes | see Wiebe 1999 | |
Notes | see Wiebe 1999 | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment (selection bias) | Low risk | A ‐ Adequate |